Breast Cancer — 5-Minute Journal Club Issue 3 with Dr Kevin Kalinsky: Defining the Role of TROP2-Directed Antibody-Drug Conjugates

From Oncology Today with Dr Neil Love Dr. Neil Love

Dr Kevin Kalinsky from the Winship Cancer Institute of Emory University in Atlanta, Georgia, discusses recent developments with TROP2-directed antibody-drug conjugates in the management of breast cancer.

CME information and select publications here.

Community discussion

Join the conversation

Breast Cancer — 5-Minute Journal Club Issue 3 with Dr Kevin Kalinsky: Defining the Role of TROP2-Directed Antibody-Drug Conjugates

You May Also Like

The Grave Talks | Haunted, Paranormal & Supernatural

HOLOSKY PODCAST

Hidden Brain

Research Insights, a Society of Actuaries Podcast

The Resetter Podcast with Dr. Mindy

Radiowissen

The Best of Coast to Coast AM

The 365 Days of Astronomy

Real Ghost Stories Online

Breaking Down: Collapse